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Abstract
Introduction
Practice facilitation involves trained individuals working with
practice staff to conduct quality improvement activities and sup-
port delivery of evidence-based clinical services. We examined the
feasibility of using practice facilitation to assist federally qualified
health centers (FQHCs) to increase colorectal cancer screening
rates in North Carolina.
Methods
The  intervention  consisted  of  12  months  of  facilitation  in  3
FQHCs. We conducted chart audits to obtain data on changes in
documented recommendation for colorectal cancer screening and
completed screening. Key informant interviews provided qualitat-
ive data on barriers to and facilitators of implementing office sys-
tems.
Results
Overall,  the percentage of eligible patients with a documented
colorectal cancer screening recommendation increased from 15%
to 29% (P < .001).  The percentage of patients up to date with
colorectal cancer screening rose from 23% to 34% (P = .03). Key
informants in all 3 clinics said the implementation support from
the practice facilitator was critical for initiating or improving of-
fice systems and that modifying the electronic medical record was
the biggest challenge and most time-consuming aspect of imple-
menting office systems changes. Other barriers were staff turnover
and reluctance on the part of local gastroenterology practices to
perform free or low-cost diagnostic colonoscopies for uninsured or
underinsured patients.
Conclusion
Practice facilitation is a feasible, acceptable, and promising ap-
proach for supporting universal  colorectal  cancer screening in
FQHCs. A larger-scale study is warranted.
Introduction
US federally qualified health centers (FQHCs) have joined the
“80% by 2018” initiative sponsored by the National Colorectal
Cancer Roundtable, which has the goal of bringing organizations
together to screen 80% of adults aged 50 to 75 years for colorectal
cancer (CRC) by 2018 (1). To achieve this goal, FQHCs must shift
from an opportunistic approach to a universal approach, whereby
every eligible patient is offered screening. Although some FQHCs
can make this shift on their own, others need support to do so (2).
Practice facilitation is a promising strategy for providing such sup-
port. Practice facilitation involves sending trained individuals to
work with clinic staff to implement office systems (eg, screening
reminders, tracking systems, decision aids, communication tools)
that help providers use and sustain evidence-based practices (3).
Practice facilitation is effective in improving preventive service
delivery and chronic disease management in primary care prac-
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tices (4). However, its feasibility has not been tested in FQHCs,
and whether its effectiveness applies to FQHCs is unclear. Prac-
tice facilitation has been tested primarily in private practices, in
countries with universal health insurance, or in clinics participat-
ing in provider-based research networks (5–16). FQHCs differ
from these settings in that they operate in medically underserved
communities, see patients with little or no insurance, provide a
range of services, and face additional regulatory and funding re-
quirements.
We conducted a pilot study to assess whether practice facilitation
could help FQHCs implement office systems needed to shift to
universal CRC screening. By using an evidence-informed tool kit
(17), a practice facilitator provided assessment, training, technical
assistance, and feedback for 12 months to 3 North Carolina FQHC
clinics. In addition to reporting changes in recommendation for
and completion of CRC screening, we describe facilitators of and
barriers to implementing office systems in FQHCs by using the
practice facilitation and tool kit approach.
Methods
Study design and conceptual model
We used a mixed-methods, one-group, pre/post study design, with
the individual FQHC clinic serving as the unit of analysis. This
study design is suitable for exploratory or developmental research
and is commonly used in feasibility studies (18).
The study was guided by an organizational model of implementa-
tion that we developed previously (Figure) (19,20). The model
posits that consistent, high-quality delivery or use of an evidence-
based practice, such as US Public Health Service CRC screening
guidelines (implementation effectiveness), is a function of 1) the
office systems that a clinic employs (implementation policies and
practices); 2) the technical assistance provided by the practice fa-
cilitator (implementation support); and 3) the resulting perception
among clinic staff that consistent, high-quality delivery or use of
an evidence-based practice is expected, supported, and rewarded
(implementation climate). The practice facilitator supports the im-
plementation of office systems and strengthens the implementa-
tion climate by reinforcing the priority of universal CRC screen-
ing.
Figure.  Organizational  model  of  innovation  implementation,  study  on
colorectal  cancer screening in community  health centers,  North Carolina,
2012–2013. Abbreviation: TA, technical assistance.
 
Study setting
At the time of the study, North Carolina had 26 FQHCs delivering
services in 120 clinical sites to nearly 400,000 patients, 70% of
whom lived below the federal poverty level, half of whom were
uninsured, and 23% of whom were age 50 years or older (21).
With assistance from the North Carolina Community Health Cen-
ter Association, we recruited 3 FQHCs with 5 clinical sites for
participation from the 20 that were within a 2-hour driving dis-
tance of where the practice facilitator was based and that had an
electronic medical record (EMR) system in place. Three FQHCs
were selected on the basis of their leadership’s high interest in
CRC screening and identification of a “project champion” to en-
sure that clinics could continue assessment and improvement work
between practice facilitator visits. One FQHC with 2 clinical sites
dropped out early in the study, preferring to address barriers to
CRC screening without assistance from the practice facilitator. Ta-
ble 1 describes the 3 clinics from the 2 FQHCs that participated in
the study.
Implementation strategy
Starting in April 2012, each clinic received practice facilitation for
12 months from a professional with a master of public health de-
gree with quality improvement experience. As a participation in-
centive, practices received a cash payment and a supply of immun-
ological  fecal  occult  blood test  (iFOBT) kits  and mailers.  We
chose to provide iFOBT kits, because North Carolina does not
have state funding for CRC screening for people who are unin-
sured. During initial visits, the practice facilitator inventoried clin-
ics’ existing resources and office systems for CRC screening and
conducted in-service education on the US Public Health Service’s
CRC screening guidelines. In subsequent visits, the practice facil-
itator worked with clinic staff to select and implement policies and
procedures from a tool kit developed by the National Colorectal
Cancer Roundtable (22) and adapted by the research team for use
in FQHCs. The tool kit included evidence-based tools to support
universal CRC screening based on US Preventive Services Task
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Force (USPSTF) guidelines (23). Tool kit components include of-
fice systems for CRC screening that fit the practice, its patients,
and local conditions; communication systems to support shared in-
formed decision making; and reminder systems to cue providers
and patients to take action. The evidence-informed tool kit was
created with input from FQHC providers and staff, and the evid-
ence-based practice facilitation model was designed to be flexible
and responsive to the needs of the clinics. The research team cre-
ated  additional  tools  such  as  a  sample  clinic  self-assessment,
screening algorithm, and iFOBT policy; sample counseling scripts
and links to patient materials and decision aids; and a sample in-
tegrated summary, tracking log, and letters to remind patients to
return iFOBT kits. During the 12-month intervention period, clin-
ics received between 12 and 19 visits from the practice facilitator
(Table 1). Average visit length ranged from 60 to 120 minutes.
Data collection and analysis
We conducted  pre/post  intervention  chart  audits  to  determine
changes in the percentage of patients with a documented recom-
mendation  for  CRC screening  and  who  were  up  to  date  with
screening. We used the USPSTF definition of “up to date,” which
is receipt of an iFOBT within the past year or a colonoscopy with-
in the past 10 years (23). We randomly selected 100 charts per
clinic  for  patients  aged 50 to  75 years  who had not  been dia-
gnosed with CRC and had at least 1 visit between January 1, 2011,
and October 31, 2011 (preintervention), and June 1, 2013, and
March 31, 2014 (postintervention). We abstracted 300 charts pre-
intervention and 255 charts postintervention. The number of charts
was not equivalent for the 2 points because one of the clinic sites
began to integrate their patient records into the main site’s EMR,
whereas previously the 2 systems had been separate. Fisher’s ex-
act tests were used to compare preintervention and postinterven-
tion rates within clinics. For overall estimates, generalized estimat-
ing equation models with a logistic link were used to perform lo-
gistic regression, while accounting for the variability or clustering
among patients within separate clinics. Differences among demo-
graphic variables such as race/ethnicity, sex, and insurance status
were examined.  All analyses were conducted using SAS statistic-
al software, version 9.3 (SAS Institute, Inc).
We also conducted 30-minute semistructured interviews postinter-
vention with 1 to 3 key informants per clinic (N = 6) including ad-
ministrators and clinicians. We inquired about facilitators of and
barriers to implementing office systems changes using the CRC
tool kit (implementation policies and practices), satisfaction with
the amount and quality of support provided by the practice facilit-
ators (implementation support), and the extent to which systemat-
ic CRC screening was expected, supported, and rewarded (imple-
mentation climate).  Interviews were recorded, transcribed ver-
batim, and independently coded by 2 qualitative analysts using
ATLAS.ti  and a starting list  of  codes keyed to the conceptual
framework, supplemented by codes that emerged during analysis.
Results
Overall, the percentage of eligible patients who received a docu-
mented recommendation for CRC screening increased from 15%
preintervention to 29% postintervention (P < .001). Nonwhite pa-
tients were significantly more likely to receive a recommendation
during the preintervention period (22% vs 12%, P < .001), but this
difference did not persist during postintervention (33% vs 27%, P
=  .13).  White  and  nonwhite  patients  rose  to  similar  levels  of
screening recommendations. No differences were seen in the rate
of recommendation between insurance categories.
The difference in receipt of a recommendation at postintervention
compared with preintervention remained significant, even after
controlling for race and insurance (odds ratio [OR] = 2.28; 95%
confidence interval [CI], 1.36–3.82; P = .002). Clinic A experi-
enced  a  significant  25  percentage  point  absolute  increase  in
screening recommendations (12% to 37%, P < .001), and Clinic C
experienced a 15 percentage point absolute increase (23% to 38%,
P = .06) (Table 2). With the assistance of the practice facilitator,
clinics transitioned from primarily referring patients for screening
colonoscopy, which many patients could not afford, to primarily
offering iFOBT first. Across all 3 clinics, the percentage who re-
ceived a recommendation for iFOBT as opposed to colonoscopy
increased from 20% preintervention to 64% postintervention (P <
.001).
Overall, the percentage of patients who were up to date with CRC
screening rose from 23% preintervention to 34% postintervention
(P = .03). In Clinic A, the percentage rose significantly from 13%
preintervention to 35% postintervention (P < .001). In Clinic C the
percentage rose from 23% to 33%, but the change was not signi-
ficant (P = .25) (Table 2). There were no differences by race/ethni-
city, sex, or insurance status.
Facilitators and barriers
All 3 clinics implemented office systems changes to support uni-
versal screening such as reminders, tracking logs, and referral sys-
tems. The fact that the evidence-informed tool kit was created with
input from FQHC providers and staff likely enhanced its usability
and effectiveness. Key informants in all 3 clinics cited the imple-
mentation support from the practice facilitator as critical for initi-
ating new office systems or improving existing ones. One pro-
vider illustrated this point by saying,
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[She] has helped us to set up some tracking processes and made
sure that we get it [the iFOBT kit] back. That’s been another prob-
lem: giving the kit, and it doesn’t come back. She helped us to de-
velop processes to get those patients contacted, so we can get the
kit back or if they lost it they can get another one. And there have
been a few cases of saved colon cancer. [Clinic B, MD, male]
Assistance with reprogramming data fields in the EMR and back-
entering CRC screening information was the most time-intensive,
yet valuable, role for the practice facilitator, given the importance
of EMRs in monitoring the quality and success of screening pro-
grams.
Key informants also reported that the tool kit complemented on-
site technical assistance, although some tools were more helpful
than others. Providers found useful the clinic self-assessment sur-
vey, the sample screening algorithm, the standing orders for CRC
screening, the tracking log, and the patient reminders. Providers
found less useful the patient counseling scripts (too long), the pa-
tient decision aides (too time-consuming), and the integrated sum-
mary (paper-based, not EMR-ready). Key informants appreciated
flexibility in how they implemented tools. For example, all 3 clin-
ics initially used the HIPAA (Health Insurance Portability and Ac-
countability Act)–compliant postcard reminders included in the
tool kit but later switched to a letter that could be loaded into the
EMR.
Key informants in all 3 clinics noted that modifying the EMR was
the biggest challenge and most time-consuming aspect of imple-
menting office systems changes. One of the first tasks for the prac-
tice facilitator was to reprogram the reminders so that they did not
keep showing up after the screening had been completed. Another
task was to make sure that the new reminders were scheduled with
appropriate intervals for screening. One participant described the
importance of shifting from tracking distribution of iFOBT kits on
paper to tracking in the EMR:
We are going to have to find work arounds to augment what the
EMR does to help us achieve the outcomes that we want to for our
patients . . . because it is superfluous to have 15 different logs in a
1-inch binder, and you’re flipping through to find whichever one you
need to. [Clinic A, MD, male]
Although none of the EMRs had ideal tracking and reminder func-
tions, clinic personnel realized that automated systems are critical
in adhering to CRC screening guidelines.
Other barriers included staff turnover, which caused clinics to re-
distribute staff roles and train new staff in the clinic’s office sys-
tems, and reluctance on the part of local gastroenterology (GI)
practices to perform free or low-cost diagnostic colonoscopies for
uninsured or underinsured patients. One clinic had agreements
with local GI practices; the other 2 did not. Despite repeated at-
tempts, these clinics could not get local GI physicians to offer dis-
counted care and had to make arrangements with an academic
medical center 2 hours away.
The implementation support that clinics received and the office
systems changes they implemented produced a positive imple-
mentation climate for universal CRC screening:
. . . I think we learned a lot, we’ve improved our screening numbers,
and I think our patients are more engaged. . . . I know my staff and
providers are aware of it now and doing a better job. And more im-
portantly for me, I think we are developing systems now to make
sure that we do a better job with the follow up. [Clinic B, MD, male]
Key informants from all 3 clinics noted that CRC screening is now
considered a top priority and, in one clinic, CRC screening is dis-
cussed in every staff meeting. Implementing standing orders em-
powered nurses to give screening tests to patients and explain how
to use them before the provider enters the exam room. Assigning
medical assistants and front desk staff responsibility for maintain-
ing the tracking log and patient reminders made the clinic’s effort
to institute universal CRC screening a “team sport.” In one clinic,
however, key informants acknowledged that clinic administration
could have done more upfront to set expectations for staff, make
time to work with the practice facilitator, and implement office
systems changes. Key informants at another clinic noted that com-
peting priorities for both providers and patients had acted as a
“double whammy” that  limited the frequency with which pro-
viders recommended screening and patients adhered to the recom-
mendation.
Discussion
The results of this pilot study indicate that practice facilitation is a
feasible, acceptable, and promising approach for assisting FQHCs
to implement office systems changes that support universal CRC
screening. In 3 recent studies of practice facilitation and CRC
screening, 2 had no significant results (7,24), and one resulted in a
16% increase in screening rates in the intervention group (25). In
our study, which took place exclusively in FQHCs, we achieved
an increase of 11 percentage points in patients who were up to
date with screening. Although a larger scale test of this approach
in the FQHC environment is needed, our results suggest that the
practice facilitation strategy can be extended from the private
practice setting to FQHCs despite differences in patient popula-
tions served, scope of services provided, and funding and regulat-
ory requirements. Practice facilitation is a more intensive, and
therefore more costly, approach to implementing office systems
changes than “lighter touch” approaches, such as provider educa-
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tion or expert consultation. Adaptive trial designs such as the Se-
quential Multiple Assignment Randomized Trial (SMART) (26)
could be useful for generating evidence about how to modulate the
intensity of practice facilitation based on FQHCs’ early respons-
iveness to the approach. Responsiveness measures could include
the level of provider engagement, number of plan–do–study–act
cycles completed, or number of office systems changes implemen-
ted.
Qualitative results offer insights into why some of the participat-
ing clinics were more successful than others. The clinic that exper-
ienced the most significant improvements had a nurse who was
actively engaged with the practice facilitator, even though she was
not  originally  identified  as  being  the  project  champion.  She
changed general clinic policies and took charge of the iFOBT kit
distribution without significant effort on the part of the physicians.
This clinic was also transitioning from paper charts to an EMR
system, which provided an opportunity to create screening docu-
mentation and reminders for all eligible patients as their records
went online. The second clinic that demonstrated improvement
was a single-provider office, and the physician showed a keen in-
terest in working with the practice facilitator to update all of her
patient records to accurately reflect CRC screening activities and
completion rates. Because the provider had a high degree of con-
trol in terms of ensuring that changes that were implemented (eg,
distributing a patient survey to get feedback on the type of iFOBT
kit that was being used), there were very few barriers to adopting
strategies from the tool kit. The third clinic in our sample did not
engage in the same high level of implementation activities, which
the practice facilitator attributed to a “disconnect” between the
quality improvement coordinator with whom she worked and the 2
clinicians  who  were  directly  responsible  for  recommending
screening and distributing iFOBT kits. This same clinic, however,
began the study without any type of iFOBT program in place and
relied solely on referring insured patients for colonoscopies. They
did succeed in implementing policies and procedures for includ-
ing iFOBT kits as a screening option, which represents a major
shift in clinical care. These qualitative results suggest that leader-
ship, readiness, communication, and other features of the “inner
context” (27) can moderate the effectiveness of practice facilita-
tion  in  promoting  office  systems  changes  for  universal  CRC
screening.
A lesson learned concerns the organizational level at which the
practice facilitator intervened. FQHCs often have multiple clinical
sites; we chose to implement the intervention and collect data at
the clinic level rather than the FQHC level. This approach worked
well for 2 FQHCs, but the FQHC that stopped participating did so
because  CRC screening  activities  were  generally  managed  at
headquarters rather than individual clinics. When the practice fa-
cilitator attempted to identify project champions and make site vis-
its, it became clear that providers and staff had little to do with
CRC screening office systems. Quality improvement team mem-
bers at the lead organization were responsible for tasks such as
identification of patients due for screening, making referrals for
colonoscopies, and ensuring transportation for colonoscopies. As
the study progressed, leadership did not feel that practice facilita-
tion would add value to their existing efforts. Like private prac-
tices, many FQHCs are joining accountable care organizations or
affiliating with health care systems (28). Future research should
account for varying degrees of organizational embeddedness of
clinical sites. Practice facilitation may need to implement multi-
level strategies that target higher organizational levels to create an
enabling, supportive context for office systems changes at the clin-
ic level.
Acknowledgments
This study was funded by the National Institutes of Health, Na-
tional Cancer Institute (no. 1R21CA161657-01), the Centers for
Disease Control and Prevention (no. U48- DP005017-01S8), and
the National Center for Advancing Translational Sciences (no.
UL1TR001111).  We thank the FQHCs for participating in our
study,  Mark  Kramer  and  Steve  Partin  at  the  UNC Lineberger
Comprehensive Cancer Center, and Benjamin Money at the North
Carolina Community Health Center Association.
Author Information
Corresponding Author:  Bryan J.  Weiner,  PhD,  Department  of
Global  Health,  University  of  Washington,  1510 San Juan  Rd,
Seattle,  WA  98195.  Telephone:  206-221-7882.  Email:
bjweiner@uw.edu.
Author Affiliations: 1Department of Global Health, University of
Washington, Seattle, Washington. 2University of North Carolina at
Chapel Hill, Chapel Hill, North Carolina. 3Philadelphia College of
Osteopathic  Medicine,  Philadelphia,  Pennsylvania.  4North
Carolina Community Health Center Association, Raleigh, North
Carolina.
References
Tools  and resources  — 80% by 2018:  National  Colorectal
Cancer Roundtable. http://nccrt.org/tools/80-percent-by-2018/.
Accessed September 15, 2016.
  1.
PREVENTING CHRONIC DISEASE VOLUME 14, E66
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY       AUGUST 2017
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2017/16_0454.htm • Centers for Disease Control and Prevention       5
Baker DW, Liss DT, Alperovitz-Bichell K, Brown T, Carroll
JE,  Crawford P,  et  al.  Colorectal  cancer  screening rates  at
community health centers that use electronic health records: a
cross sectional study. J Health Care Poor Underserved 2015;
26(2):377–90.
  2.
Mathematica  Policy  Research.  Developing  and  running  a
primary care  practice  facilitation program: a  how-to guide
(AHRQ publication no. 12-0011). Rockville (MD): Agency for
Healthcare Research and Quality; 2011.
  3.
Baskerville  NB, Liddy C, Hogg W. Systematic review and
meta-analysis  of  practice  facilitation  within  primary  care
settings. Ann Fam Med 2012;10(1):63–74.
  4.
Aspy CB, Mold JW, Thompson DM, Blondell RD, Landers
PS, Reilly KE, et al. Integrating screening and interventions for
unhealthy behaviors into primary care practices. Am J Prev
Med 2008;35(5,Suppl):S373–80.
  5.
Aspy  CB,  Enright  M,  Halstead  L,  Mold  JW;  Oklahoma
Physicians  Resource/Research  Network.  Improving
mammography screening using best  practices  and practice
enhancement assistants: an Oklahoma Physicians Resource/
Research Network (OKPRN) study.  J  Am Board Fam Med
2008;21(4):326–33.
  6.
Curry WJ, Lengerich EJ, Kluhsman BC, Graybill MA, Liao
JZ,  Schaefer  EW,  et  al.  Academic  detailing  to  increase
colorectal  cancer  screening  by  primary  care  practices  in
Appalachian  Pennsylvania.  BMC  Health  Serv  Res  2011;
11(1):112.
  7.
Dickinson WP, Dickinson LM, Nutting PA, Emsermann CB,
Tutt  B,  Crabtree BF,  et  al.  Practice  facilitation to  improve
diabetes  care  in  primary  care:  a  report  from  the  EPIC
randomized clinical trial. Ann Fam Med 2014;12(1):8–16.
  8.
Due TD, Thorsen T, Kousgaard MB, Siersma VD, Waldorff
FB.  The  effectiveness  of  a  semi-tailored  facilitator-based
intervention to optimise chronic care management in general
practice: a stepped-wedge randomised controlled trial. BMC
Fam Pract 2014;15:65.
  9.
Grunfeld E,  Manca D, Moineddin R, Thorpe KE, Hoch JS,
Campbell-Scherer  D,  et  al..  Improving  chronic  disease
prevention  and  screening  in  primary  care:  results  of  the
BETTER pragmatic cluster randomized controlled trial. BMC
Fam Pract 2013;14:175.
10.
Hogg W, Lemelin J, Moroz I, Soto E, Russell G. Improving
prevention in primary care:  evaluating the sustainability of
outreach facilitation. Can Fam Physician 2008;54(5):712–20.
11.
Hogg  W,  Lemelin  J,  Graham  ID,  Grimshaw  J,  Martin  C,
Moore  L,  et  al.  Improving  prevention  in  primary  care:
evaluating the effectiveness of outreach facilitation. Fam Pract
2008;25(1):40–8.
12.
Jaén CR, Crabtree BF,  Palmer RF,  Ferrer  RL,  Nutting PA,
Miller  WL,  et  al.  Methods  for  evaluating  practice  change
toward a patient-centered medical home. Ann Fam Med 2010;
8(Suppl 1):S9–20, S92.
13.
Liddy  C,  Hogg  W,  Singh  J,  Taljaard  M,  Russell  G,  Deri
Armstrong  C,  et  al.  A  real-world  stepped  wedge  cluster
randomized  trial  of  practice  facilitation  to  improve
cardiovascular care. Implement Sci 2015;10(1):150.
14.
Mold JW, Fox C,  Wisniewski  A,  Lipman PD,  Krauss  MR,
Harris  DR,  et  al.  Implementing  asthma  guidelines  using
practice  facilitation  and  local  learning  collaboratives:  a
randomized  control led  tr ial .  Ann  Fam  Med  2014;
12(3):233–40.
15.
Shaw EK,  Ohman-Strickland PA,  Piasecki  A,  Hudson SV,
Ferrante JM, McDaniel RR Jr, et al. Effects of facilitated team
meetings  and  learning  collaboratives  on  colorectal  cancer
screening rates in primary care practices: a cluster randomized
trial. Ann Fam Med 2013;11(3):220–8, S1–8.
16.
Rohweder C, Wolf M, Schenck A, Prasad V, Diehl S. Options
for  increasing  colorectal  cancer  screening  rates  in  North
Carolina community health centers. Chapel Hill (NC): UNC
Lineberger Comprehensive Cancer Center; January 2011.
17.
Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L,
Weiner D, et al. How we design feasibility studies. Am J Prev
Med 2009;36(5):452–7.
18.
Helfrich  CD,  Weiner  BJ,  McKinney  MM,  Minasian  L.
Determinants  of  implementation  effectiveness:  adapting  a
framework for complex innovations. Med Care Res Rev 2007;
64(3):279–303.
19.
Weiner BJ, Lewis MA, Linnan LA. Using organization theory
to understand the determinants of effective implementation of
worksite health promotion programs. Health Educ Res 2009;
24(2):292–305.
20.
North Carolina’s community health centers facts at a glance
2008. Raleigh (NC): North Carolina Community Health Center
Association;  2008.  http://www.ncchca.org.  Accessed
September 15, 2016.
21.
Sarfaty M. How to increase colorectal cancer screening rates in
practice: a primary care clinician’s evidence-based toolbox and
guide 2008. Peterson K, Wender R, editors. Atlanta (GA): The
American  Cancer  Society,  the  National  Colorectal  Cancer
Roundtable, and Thomas Jefferson University; 2006[revised
2008]. http://www.cancer.org/acs/groups/content/documents/
document/acspc-024588.pdf. Accessed September 15, 2016.
22.
US Preventive Services Task Force. Screening for colorectal
cancer, topic page. Rockville (MD): Agency for Healthcare
Research and Quality; 2009. http://www.ahrq.gov/clinic/uspstf/
uspscolo.htm. Accessed September 15, 2016.
23.
PREVENTING CHRONIC DISEASE VOLUME 14, E66
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY       AUGUST 2017
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
6       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2017/16_0454.htm
Mold  JW,  Aspy  CA,  Nagykaldi  Z;  Oklahoma  Physicians
Resource/Research  Network.  Implementation  of  evidence-
based preventive services delivery processes in primary care:
an  Oklahoma  Physicians  Resource/Research  Network
(OKPRN) study. J Am Board Fam Med 2008;21(4):334–44.
24.
Dignan  M,  Shelton  B,  Slone  SA,  Tolle  C,  Mohammad  S,
Schoenberg N, et al. Effectiveness of a primary care practice
intervention  for  increasing  colorectal  cancer  screening  in
Appalachian Kentucky. Prev Med 2014;58:70–4.
25.
Collins  LM,  Murphy  SA,  Strecher  V.  The  Multiphase
Optimization Strategy (MOST) and the Sequential Multiple
Assignment Randomized Trial (SMART): new methods for
more  potent  eHealth  interventions.  Am J  Prev  Med  2007;
32(5,Suppl):S112–8.
26.
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander
JA, Lowery JC. Fostering implementation of health services
research findings into practice: a consolidated framework for
advancing  implementation  science.  Implement  Sci  2009;
4(1):50.
27.
Lewis VA, Colla CH, Schoenherr KE, Shortell SM, Fisher ES.
Innovation in  the safety net:  integrating community health
centers  through accountable  care.  J  Gen Intern  Med 2014;
29(11):1484–90.
28.
PREVENTING CHRONIC DISEASE VOLUME 14, E66
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY       AUGUST 2017
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2017/16_0454.htm • Centers for Disease Control and Prevention       7
Tables
Table 1. Clinic Characteristics, Study on Colorectal Cancer Screening in Community Health Centers, North Carolina, 2012–2013
Characteristic
Clinic, Geographic Location
Clinic A, Rural Clinic B, Rural Clinic C, Urban
Staffing
2 MDs, 1 PA, 5 RNs, 2 medical
assistants, 2 laboratory technicians
1 MD, 1 PA, 1 CNM, 2 LPNs, 1
medical assistant
1 MD, 1 PA, 1 LPN, 1 medical
assistant
Patient population, age 773 patients, >50 y 1,884 patients, > 50 y 1,365 patients, >50 y
No. of practice facilitator visits 12 19 18
Average visit duration Approximately 2 h Approximately 1 h 45 min Approximately 1 h
Abbreviations: CNM, certified nurse midwife; LPN, licensed practical nurse; MD, medical doctor; PA, physician assistant; RN, registered nurse.
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Table 2. Effects of Practice Facilitation on CRC Screening Rates, Recommendations for Screening, and Recommendations for iFOBT, Study on CRC Screening in
Community Health Centers, North Carolina, 2012–2013
Clinic Name (Pre/Post No.) Preintervention, % (n) Postintervention, % (n) Percentage Point Change P Value
Patients up-to-date with CRC screening
A (n = 100; n = 100) 13 (13) 35 (35) 22 <.001
B (n = 100; n = 100) 32 (32) 35 (35) 3 .76
C (n = 100; n = 55) 23 (23) 33 (18) 10 .25
All (n = 300; n = 255) 23 (68) 34 (88) 11 .03
Patients who received documented CRC screening recommendation
A (n = 100; n = 100) 12 (12) 37 (37) 25 <.001
B (n = 100; n = 100) 11 (11) 16 (16) 5 .41
C (n = 100; n = 55) 23 (23) 38 (21) 15 .06
All (n = 300; n = 255) 15 (46) 29 (74) 14 <.001
Patients recommended for iFOBT screening
A (n = 12; n = 37) 33 (4) 65 (24) 32 .09
B (n = 11; n = 16) 0 63 (10) 63 .001
C (n = 23; n = 21) 22 (5) 62 (13) 40 .01
All (n = 46; n = 74) 20 (9) 64 (47) 44 <.001
Abbreviations: CRC, colorectal cancer; iFOBT, immunochemical fecal occult blood test.
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